Cite
HARVARD Citation
van der Kroef, M. et al. (2019). Histone modifications underlie monocyte dysregulation in patients with systemic sclerosis, underlining the treatment potential of epigenetic targeting. Annals of the rheumatic diseases. 78 (4), pp. 529-. [Online].